- Allantoin 10.25mg / Lidocaine 10.25mg suppositories
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Allantoin 10.25mg / Lidocaine 10.25mg suppositories | Start Date 01-12-2003 | End Date |
Previous Name | Previous Name Allantoin 10.25mg / Lignocaine 10.25mg suppositories | Start Date 05-03-2003 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- suppository
- Unit Dose UOM
- suppository
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Rectal
- Form
- Suppository
- Ontology Form/Route
- suppository.rectal
- Name Basis
- Other
Codes
- ATC Code
- C05AX03
BNF | Start Date | End Date |
---|---|---|
Current BNF 01070100 | Start Date 04-04-2022 | End Date |
Previous BNF 01070100 | Start Date 04-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
4017911000001105 | 05-03-2003 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Allantoin | Based on Ingredient Substance | 10.25 mg | ||
Lidocaine hydrochloride | Based on Ingredient Substance | 10.25 mg |
Name
Allantoin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.25
Strength and UOM (Dmr)
Name
Lidocaine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.25
Strength and UOM (Dmr)
Parent Products
-
VTMAllantoin + Lidocaine
-
VMP(Current) Allantoin 10.25mg / Lidocaine 10.25m...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
6 suppository | ||
12 suppository | 311 | Part VIIIA Category C |